newsfilter
← Latest News
GlobeNewswire·

NeOnc Technologies to Be Featured on Health Uncensored with Dr. Drew to Discuss Reaching Brain Tumors Without Surgery or Systemic Chemotherapy

  • NeOnc Technologies Holdings, Inc. will appear on the Fox Business Network program "Health Uncensored with Dr. Drew" on Sunday, October 25, 2026, at 5:30 p.m. ET.
  • The segment will feature Executive Chairman Amir F. Heshmatpour and Chief Medical Officer Thomas Chen, MD, PhD, discussing the company's non-invasive intranasal approach for brain tumors.
  • The discussion focuses on the investigational intranasal NEO100 program, a highly purified form of perillyl alcohol designed to bypass the blood-brain barrier without surgery or systemic chemotherapy.
  • NEO100 is currently in clinical development for both adults and children, though its safety and efficacy remain unestablished.
  • NeOnc also develops oral NEO212, which has completed Phase 1 dose escalation and is advancing toward Phase 2.
  • The company exclusively licenses a worldwide patent portfolio related to NEO100, NEO212, and other drug candidates from the University of Southern California.
  • The press release includes standard forward-looking statements noting that NEO100 is investigational and has not received regulatory approval.